Upstate Active Clinical Trials
Study Title:RTOG 1016 - Phase III Trial of Radiotherapy Plus Cetuximab Versus Chemoradiotherapy in HPV-Associated Oropharynx Cancer
What is the purpose of the study?This phase III trial is studying radiation therapy with cisplatin or cetuximab to see how well it works in treating patients with oropharyngeal cancer.
Upstate Institutional Review Board (IRB) Number:351373
Patient Age Group:Adults
Principal Investigator:Michael A Lacombe, MD
Who can I contact for more information?
Name: Dena R Martin